


PECE PLATFORM WITH TM-FLOW
MEDICAL DEVICE SYSTEM
Physicians and Distributors, We Are Proud to Offer
You the TM-Flow ANS Testing Medical Device System
With PECE an Advanced Medical Software Platform
The complete ANS testing medical device platform and managed services for your practice.
Your Details
THE 8 RISK FACTOR AREAS eXAMINED
Early detection and follow-up of autonomic nervous system and vascular system complications by measuring 8 health risk areas within your body.
Autonomic Nervous System Dysfunction

Insulin Resistance

Endothelial Dysfunction.

Sudomotor Dysfunction

Cardiac Autonomic Neuropathy

Cardio- Metabolic Risk

Small Fibre Neuropathy

Cardio-vascular Disease

INCREASE IN POTENTIAL REVENUE FOR YOUR MEDICAL PRACTICE
PECE platform with TM-Flow medical device system put the power of volume-based “Good Medicine” in your hands
ADDITIONAL TESTING VALIDATION
With our comprehensive and instructional ANS test reports, you will have access to credible
testing criteria (based on validated medical markers). These criteria establish the medical necessity
for over 21 validated additional tests for continued and accurate patient diagnosis!
OUR SYSTEM COMES WITH 2 MAJOR TOOLS FOR THE
360-DEGREE OPERATIONS OF OUR PROGRAMS.

pece medical device platform

tm-flow medical device
THE NON-INVASIVE METHODS UTILIZE BY THE TM-FLOW
DEVICE FOR ASSESSING VASCULAR FUNCTION COMPRISE OF
THE PATIENT REPORT VIEW FROM THE PECE
TM-FLOW MEDICAL DEVICE PLATFORM
PECE platform enables “GOOD MEDICINE” through better
actionable medicaldata about patient condition.
The test results from your ANS device are integrated into the software algorithm to give
your practice ACTIONABLE DATA that will immediately improve treatment measures,
preventing potential life-threatening diseases.
UTILIZE YOUR ANS MEDICAL DEVICE BETTER TO
IMPROVE YOUR BOTTOM-LINE
WHY SHOULD YOU WORK WITH US??
Our unique ANS testing program and our continued fully managed services
have helped separate us from the others in the industry and set new standards
in the medical industry.
DISCUSSION ON OUR ANS TESTING MEDICAL DEVICE PLATFORM
AND ITS VALUE TO PATIENTS WITH DOCTOR OF NEUROLOGY.

Dr. Mahmood has a clear understanding of our testing model and improves patient care for his practice.
Cardio-autonomic neuropathy and small fiber neuropathy diagnosis cannot be how it made with routine laboratory tests and clinical examination alone. Both conditions can lead to a change in management depending on the patient’s symptoms and the diagnosis. For example, patients with cardiovagal impairment can be advised to use compression stockings, or for more severe cases, fludrocortisone can be used or midodrine. In addition, patients can avoid skin biopsy with a small fiber neuropathy diagnosis with this test.


